JP2024540673A5 - - Google Patents

Info

Publication number
JP2024540673A5
JP2024540673A5 JP2024531608A JP2024531608A JP2024540673A5 JP 2024540673 A5 JP2024540673 A5 JP 2024540673A5 JP 2024531608 A JP2024531608 A JP 2024531608A JP 2024531608 A JP2024531608 A JP 2024531608A JP 2024540673 A5 JP2024540673 A5 JP 2024540673A5
Authority
JP
Japan
Prior art keywords
acid
compound
pharmaceutical product
rheumatoid arthritis
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024531608A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024540673A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2022/083624 external-priority patent/WO2023094692A1/en
Publication of JP2024540673A publication Critical patent/JP2024540673A/ja
Publication of JP2024540673A5 publication Critical patent/JP2024540673A5/ja
Pending legal-status Critical Current

Links

JP2024531608A 2021-11-29 2022-11-29 関節リウマチの治療 Pending JP2024540673A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21211179.3 2021-11-29
EP21211179 2021-11-29
PCT/EP2022/083624 WO2023094692A1 (en) 2021-11-29 2022-11-29 Treatment of rheumatoid arthritis

Publications (2)

Publication Number Publication Date
JP2024540673A JP2024540673A (ja) 2024-10-31
JP2024540673A5 true JP2024540673A5 (https=) 2025-12-08

Family

ID=78821593

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024531608A Pending JP2024540673A (ja) 2021-11-29 2022-11-29 関節リウマチの治療

Country Status (5)

Country Link
US (1) US20250032449A1 (https=)
EP (1) EP4440572A1 (https=)
JP (1) JP2024540673A (https=)
CN (1) CN118613260A (https=)
WO (1) WO2023094692A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025124760A1 (en) * 2023-12-11 2025-06-19 Synact Pharma Aps Treatment of subpopulation of patients with rheumatoid arthritis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3773558T (lt) * 2019-05-10 2022-09-12 Synact Pharma Aps Kompleksinis artrito gydymas

Similar Documents

Publication Publication Date Title
KR100745160B1 (ko) 멜도늄 염, 그것의 제조방법 및 그것을 주성분으로 한약학적 조성물
ES2532210T3 (es) Métodos para el tratamiento concomitante de teofilina y febuxostat
US20150273070A1 (en) Modified release of 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-n-[5-(4-methyl-1h-imidazol-1-yl)-3-(triflouoromethyl)phenyl] benzamide solubilized using organic acids
EA020193B1 (ru) Комбинации, включающие метотрексат и ингибиторы дигидрооротатдегидрогеназы (dhodh)
JP2024522817A5 (https=)
JP2550455B2 (ja) ４ーアルキルイミダゾール誘導体
JP2024507991A5 (https=)
JP2023515668A5 (https=)
US6342488B1 (en) Phosphonorisperidone and sulforisperidone compositions and methods
JP2019529570A (ja) ミドドリンの組成物およびその使用方法
JP2024540673A5 (https=)
TW200846323A (en) Bioavailable formulations of heterocyclic compounds
TWI574690B (zh) 立即釋放４－甲基－３［［４－（３－吡啶基）－２－嘧啶基］胺基］－ｎ－［５－（４－甲基－１ｈ－咪唑－１－基）－３－（三氟甲基）苯基］苯甲醯胺調配物
US6001845A (en) Combination of phentolamine and apomorphine for the treatment of human sexual function and dysfunction
JP2023524519A (ja) 炎症性腸疾患の治療
JP2023528896A5 (https=)
US6136818A (en) Combination of phentolamine and apomorphine for the treatment of human sexual function and dysfunction
CN101663035A (zh) 4－环丙基甲氧基－n－(3,5－二氯代－1－环氧－吡啶－4－基)－5－(甲氧基)吡啶－2－甲酰胺用于治疗与帕金森症有关的运动障碍的用途
JP2022550458A5 (https=)
JP4549618B2 (ja) 鼻炎用組成物
JPH05950A (ja) 利尿剤
JP2010180238A (ja) 鼻炎用組成物
JPH0873352A (ja) 高血圧治療剤
WO2004063201A1 (ja) 統合失調症治療剤
JPWO1993023360A1 (ja) 新規第４級アンモニウム塩類およびそれらの医薬としての使用